Correlation of APOE, SLCO1B1 and LPA KIV-2 gene polymorphisms with coronary heart disease in the Teochew population

Table 5 Comparison of blood lipid levels among SLCO1B1 genes

	Extensive metabolizer I (n = 249)	Intermediate metabolizer II (n = 72)	P value
TG, mmol/L	1.65 ± 1.20	1.66 ± 1.05	0.992
TC, mmol/L	4.88 ± 1.22	4.56 ± 1.08	0.119
HCY, μmol/L	13.73 ± 8.54	13.61 ± 6.54	0.801
HDL-C, mmol/L	1.10 ± 0.29	1.11 ± 0.29	0.778
LDL-C, mmol/L	3.08 ± 1.16	2.69 ± 0.91	0.016
ApoA1, g/L	1.09 ± 0.59	1.09 ± 0.21	0.256
ApoB, g/L	0.89 ± 0.37	0.79 ± 0.25	0.045
LP(a), mg/L	248.62 ± 300.96	323.28 ± 379.60	0.306
ApoE, mg/L	42.03 ± 18.17	39.96 ± 12.88	0.419

Extensive metabolizer I: *1a/*1a,*1a/*1b,*1b/*1b; Intermediate metabolizer II: *1a/*5,*1a/*15,*1b/*15. TG: Triglycerides; TC: Total cholesterol; HCY: Homocysteine; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; ApoA1: Apolipoprotein A1; ApoB: Apolipoprotein B; ApoE: Apolipoprotein E; Lp(a): Lipoprotein(a).